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Abstract 
 
Purpose: The aim of the present randomized controlled clinical study was to test 
whether small bony dehiscence defects (≤5mm) left to heal spontaneously result in 
the same clinical and radiological outcome as defects treated with guided bone 
regeneration (GBR). 
Materials and Methods: 22 patients who received at least one implant with a small 
bony dehiscence defect were enrolled in the study. If the defect height was ≤5mm 
the site was randomly assigned to either the spontaneous healing (SH) group or the 
GBR group. In the SH group the defect was left without any treatment. In the GBR 
group the defects around the implants were grafted with deproteinized bovine bone 
mineral (DBBM) and covered with a native collagen membrane. Clinical and 
radiographic measurements were performed 6 months after implant placement with 
a reentry surgery and at the time of crown insertion and the subsequent follow-up 
appointments at 3,6,12 and 18 months after loading. For statistical analyses the 
mixed linear model was applied for the clinical and radiographic measurements 
observed around the implants. Simple comparisons of the location of the 
measurements in the two independent groups are performed with the Mann-Whitney 
test. In addition the mixed model assumptions were checked. 
Results: The implant and crown survival rate 18 months after loading was 100%, 
revealing no serious biologic or prosthetic complication. The mean changes of the 
buccal vertical bone height between implant placement and reentry surgery after 6 
months revealed a small bone loss of -0.17±1.79mm (minimum -4mm and maximum 
2.5mm) for the SH group and a bone gain of 1.79±2.24mm (minimum of -2.5mm and 
maximum of 5mm) for the GBR group, respectively (p=0.017). Radiographic 
 3 
measurements demonstrated a slight bone loss of -0.39±0.49mm for the SH group 
and a stable bone level of 0.02±0.48mm for GBR group after 18 months. All 
periimplant soft tissue parameters revealed healthy tissues with no difference 
between the two groups.  
Conclusion: Small bony dehiscence defects left for spontaneous healing 
demonstrated high implant survival rates with healthy and stable soft tissues. 
However, they revealed more vertical bone loss at the buccal aspect 6 months after 
implant insertion and also more marginal bone loss between crown insertion and 18 
months after loading compared to sites treated with GBR. 
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Introduction 
In the early days of implant dentistry, the position of dental implants was mainly 
based on availability of native bone. The goal was for the implant to be surrounded 
by native bone, without creating a bone dehiscency. Recently, the concept of 
prosthetically driven implant placement has become widespread because it provides 
more favorable conditions for the prosthetic treatment. When implants are being 
placed in the prosthetically correct position, bone dehiscencies are more likely to 
occur. These defects can be successfully treated with guided bone regeneration 
(GBR) using membranes and bone substitution materials  (Berglundh & Lindhe 
1997, Hammerle & Karring 1998, Hammerle & Lang 2001, Simion et al. 1997, 
Zitzmann et al. 1997).  
However, the advantage of applying GBR to small dehiscency defect ( ≤ 5 mm) in 
the posterior area has never been documented. Small dehiscency defects left to 
spontaneous healing have been investigated in relation to implant stability 
(Carmagnola et al. 1999, Palmer et al. 1994, Rasmusson et al. 1997). These clinical 
studies showed that small dehiscency defects did not have an effect on implant 
stability. However, the effect on the peri-implant mucosa was not evaluated. The 
disadvantage of spontaneous healing is that the corono-buccal aspect of the implant 
will be covered only by mucosa instead of newly formed bone and mucosa. This 
might lead to soft tissue recession and exposition of the rough surface of the implant. 
In patients with insufficient oral hygiene, the exposed rough surface will lead to 
plaque accumulation. The formation of biofilm could result in peri-implant mucositis 
(Pontoriero et al. 1994, Zitzmann et al. 2001)  or eventually in peri-implantitis with 
bone loss. 
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These negative consequences of the exposed rough surfaces can be avoided by 
applying GBR to the small dehiscency defects. However, the application of GBR has 
also negative side effects: increased treatment and healing time, increased 
treatment cost and a higher patient morbidity, e.g. swelling or the risk for infection. In 
consideration of all these factors, it is essential that in small dehiscence defects GBR 
is only applied when it is absolutely necessary for the long-term stability and health 
of the peri-implant tissues.  
 
The aim of this study was to test whether small bony dehiscence defects (≤ 5 mm) 
left to heal spontaneously result in the same clinical and radiological outcome as 
small dehiscence defects treated with GBR using deproteinized bovine bone mineral 
(DBBM) and collagen membrane.  
  
 
Material and Methods 
The present study is a prospective, single-center, randomized, controlled clinical 
investigation. Patient recruitment, treatment and follow-ups were performed in a 
private practice environment (M.H) The clinical study protocol and all procedures and 
materials were approved by the local ethical committee of the Canton of Zurich 
(KEK) before the start of the study (Ref.Nr.: StV08/08). Informed consent was 
obtained from all patients before any study procedures were performed. The study 
was monitored by an independent study monitor to ensure consistency and 
accuracy. 
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Patients 
The study recruited 22 male or female patients in need of implant treatment in the 
posterior mandible or maxilla with an expected osseous defect of maximum 5 mm in 
vertical dimension. In addition, the local hard- and soft-tissue architecture should 
allow inserting implants in a prosthetically driven position.  
All patients were in good general health and underwent comprehensive dental care. 
18 patients were non-smokers, 2 smoked less than 10 cigarettes/day and 2 smoked 
between 10 and 20 cigarettes/day. 
Enrolled patients complied with all of the inclusion and exclusion criteria. Two of the 
inclusion criteria, such as primary stability of the dental implant and osseous 
dehiscence defects ≤ 5 mm in vertical dimension could only be evaluated at the day 
of surgery. If two or more sites were still available fulfilling the defect criterion, one 
was randomly selected for further statistical analysis. The selected site was assigned 
to a treatment according to the randomization envelope. 
In the event that a patient was found to be ineligible for the study at the time of 
surgery, an alternative treatment following good clinical standards was offered to the 
patient. 
 
Surgical procedure 
The implant placement was performed either as a delayed (between 6 weeks and 6 
months after tooth extraction) or a late procedure (more than 6 months after tooth 
extraction). Before surgery the patients received antibiotics (2 x 750 mg Clamoxyl®; 
GlaxoSmithKline AG, Münchenbuchsee, Switzerland) and analgesics/antiphlogistics 
(500 mg Mefenacid®; Streuli Pharma AG, Uznach, Switzerland). Surgery was 
performed under local anesthetic. The incision was placed at the mid-crest, with 
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releasing incisions if necessary, and a mucoperiosteal flap was raised. The implant 
site was prepared according to current standard of the Camlog System and a 
CAMLOG® SCREW-LINE implant (Camlog BiotechnologiesAG, Basel, Switzerland) 
was inserted.  
Immediately after implantation, initial implant stability was assessed by hand testing. 
If any implant lacked primary stability at this assessment, the patient was excluded 
from further participation in the study. 
The osseous defect of eligible sites was measured after implant placement with the 
help of a calibrated periodontal probe (Fig 1). If the defect height was more than 5 
mm or had no defect, the patient was excluded from the study. 
 
Measurement of defect size  
• A: Vertical defect height (mm) measured from the implant shoulder to the first 
bone-to-implant contact (BIC) (Fig. 1a). 
• B: Infrabony defect height (mm) measured from the bone crest to the first BIC 
(Fig. 1a). 
• C: Defect width (mm) measured from the mesial to the distal bone crests (Fig. 
1b). 
• D: Defect depth (mm) measured from the bone crest to the implant surface in 
a direction perpendicular to the long axis of the implant (Fig. 1a). 
 
Randomization 
If the defect height was ≤ 5 mm the site was assigned to a treatment according to 
the randomization envelope: 
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• Spontaneous healing (SH) group: The osseous defect was left without any 
treatment for spontaneous healing. The exposed implant serves was left 
untreated. 
• Guided bone regeneration (GBR) group: Osseous defects around the 
implants were grafted with a deproteinized bovine bone mineral (DBBM) 
(BioOss® Spongiosa Granules, particle size 0.25 – 1.0 mm; Geistlich Pharma 
AG, Wolhusen, Switzerland). The defect was filled with the bone substitute 
without being overfilled. Subsequently a collagen membrane of porcine origin 
was used (BioGide membrane, Geistlich Pharma AG, Wolhusen, Switzerland) 
to cover the grafting materials and the implant extending to palatal or lingual 
part of the alveolar ridge. 
 
Since healing was attempted with the implants in a submerged position, the implants 
were covered with the mucosa. Periosteal releasing incisions were used to allow 
tension-free adaptation of the flap. The patients were instructed to rinse twice daily 
with an aqueous solution of 0.2% chlorhexidine and to continue the antibiotic 
regimen for 5 days (750 mg Clamoxyl®, three times a day). In addition, analgesics 
(500 mg Mefenacid®) were prescribed for the next 2 days according to individual 
needs. Patients were also instructed to refrain from mechanical plaque removal in 
the area of implantation for 1 week.  
Suture removal was performed 1 week after surgery and another control 
appointment was scheduled 2 weeks postoperatively. 
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Reentry procedure 
Six months later, a re-entry surgery was performed to assess the results of the 
spontaneous healing or the surgical therapy. Mucoperiosteal flaps were reflected to 
allow for exact evaluation. The same clinical measurements assessed at baseline 
were again recorded (Fig. 1a to 1b) (primary parameter). Cover screws were 
replaced by healing abutments. Subsequently, the flaps were adjusted to fit around 
the neck of the healing abutment and sutured. One week later, the sutures were 
removed.  
 
Prosthetic reconstruction 
After the re-entry procedure 6 months following implant placement, the soft tissues 
were allowed to heal for at least 1 week before impression taking. Thereafter, the 
single crowns (or a fixed partial denture in one case) were incorporated, either 
screw-retained or cemented. 
 
Follow-up examinations 
All patients were enrolled in a maintenance care program during the entire study 
period of 18 months within a private practice environment. Clinical and radiographic 
assessments were performed at 3, 6, 12 and 18 months after insertion of the 
crowns.  
 
Clinical measurements 
At each time point the following parameters were examined at the enrolled implant 
during the clinical examination: 
1. Implant survival 
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2. Plaque index (PI) (Silness and Löe, 1964 (Silness & Loe 1964)). For each of 
the 4 surfaces of the implants a score of 0 to 3 is given that matches the severity. 
3. Probing pocket depths (PPD) were performed at six sites (mesio-buccal, mid-
buccal, disto-buccal, disto-lingual, mid-lingual, mesio-lingual) of each implant and 
recorded to the nearest millimeter with the periodontal probe UNC-15 using a 
force of 0.2-0.3 N (examiner M.H. was calibrated in advance).  
4. Sulcus bleeding index (Muhlemann & Son 1971) for each of the 4 surfaces of 
the implants 
5. Mucosa level (distance between mucosa margin and rough/smooth border of 
the implant). Negative values = the mucosa margin is apical to the rough/smooth 
border (6 sites per implant). 
 
Radiographic measurements 
For the evaluation of the marginal bone level, intraoral radiographs were taken using 
the long-cone paralleling technique with the central beam directed to the alveolar 
crest (Hawe x-ray film holder, Kerrhawe SA, Bioggio, Switzerland). The images were 
digitalized with a scanner (Epson Perfection V700 Pro Scanner) in a resolution of 
1200 dpi. 
The marginal bone level (MBL), i.e. the distance between the implant shoulder and 
the first visible bone-to-implant contact, was measured at the mesial and distal 
aspect with a 10-15x magnification (Buser et al. 1991, Weber et al. 1992) using an 
image analysis program (Image J, Version 1.44, U.S. National Institutes of Health, 
Bethesda, Maryland, USA). In order to adjust each radiograph for distortion they 
have been calibrated by a reference structure, which was the well-known implant 
diameter.  
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Statistical analysis 
The statistical analyses were performed applying SAS V 9.4 (SAS Institute Inc. Cary, 
North Carolina with Proc mixed).   
For the description of the data, means, minimum and maximum, standard deviations 
(SDs) and medians were derived for quantitative variables, and percentages for 
qualitative categorical variables. The statistical independent unit is the patient. 
Because of several measurements within a patient and repeated measurements in 
time, the mixed linear model was applied for the clinical and radiographic 
measurements observed around the implants. This model takes into account these 
dependencies by using patient as random. As explanatory factor we used treatment 
and time as well as their interaction.   
Since only four patients needed more than one implant, we selected at random one 
of the implants placed in a patient with more than one implant. With this slightly 
reduced data set we compared the two treatments using several continuous effect 
size measurements at surgery and at re-entry as well their difference with the Mann 
Whitney test. Also we derived the exact 95% confidence intervals for the interesting 
results to estimate the true population location difference between the two 
treatments.   
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Results 
Patients 
22 patients with a total of 28 implants were enrolled and included in the trial. Twelve 
patients with 15 implants were randomized to the spontaneous healing group (SH) 
and 10 patients with 13 implants to the guided bone regeneration group (GBR). The 
mean age was 56 years (range 40-74 years) in the SH group and also 56 years 
(range 35-75 years) in the GBR group. In the SH group there were 4 male and 8 
female patients and in the GBR group there were 6 male and 4 female patients. 
The vast majority of the patients were non-smokers (75% in the SH group and 90% 
in the GBR group).  
 
Surgical procedure and reentry 
Implant location and characteristics 
The implant locations are displayed in table 1. The majority of the implants were 
placed at the position of teeth number 36 or 46 (FDI classification).  
All types of implant lengths ranging from 9 to 13 mm and implant diameters ranging 
from 3.8 up to 5mm have been inserted according to the local anatomic and 
prosthetic requirements.  
 
Clinical observations at implant installation 
All implants obtained primary stability after insertion. Both treatment groups were 
homogeneous with regard to the baseline values of the quantitative variables 
measured. The mean vertical defect height (A in Fig. 1a) at surgery was 3.25 ± 1.18 
mm for the SH group and 3.64 ± 1.37 mm for the GBR group without any statistical 
significance difference. No violation of any anatomic structure occurred. 
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Healing period, soft tissue complications 
During the submucosal healing period of 6 months no evidence of serious local or 
systemic adverse effects was observed in any of the groups.  
In the spontaneous healing group, 2 implant sites revealed local infections after 3.5 
weeks and 3 months, respectively. Both were treated by local disinfection (rinsing 
with 0.2% chlorhexidine) and completely recovered after 3 weeks. An additional 
implant in SH group revealed a partial exposure of the cover screw, which remained 
open until reentry surgery. At re-entry, a radiolucency and infection were noticed at 
an implant in the position 46. Three weeks later at impression/abutment placement 
exudation occurred at the sulcus and peri-implantitis was noticed. Rinsing with CHX 
was prescribed (3 weeks). At definitive prosthesis placement, no clinical signs of 
infection were noted, but a peri-implant radiolucency was still present.  
In the GBR group, 2 implant sites showed a local exposure of the collagen 
membrane after 1 and 2 weeks, which was also treated by local application of CHX. 
Both recovered and demonstrated intact soft tissue coverage. One implant site 
revealed a local infection after 1 week and another implant cover screw got partially 
exposed after 12 weeks. All complications recovered except the one with the 
exposed cover screw that remained exposed until reentry surgery after 6 months. 
 
Bone measurements at re-entry 
After a healing period of 6 months, a re-entry operation was performed for abutment 
connection and to measure the residual defects. At this time point, all implants were 
stable revealing an implant survival rate of 100%.  
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The measurements of the bone defects according to Fig 1a and 1b are displayed in 
table 2. In regards to the remaining defect height (parameter A in Fig 1a), the 
spontaneous healing group revealed 5 out of 12 sites (41.66%) with a vertical bone 
loss between implant insertion and the reentry procedure 6 months later. Three sites 
remained stable (25%). Another 4 sites demonstrated a spontaneous bone gain 
(33.33%). The mean difference in vertical bone height between the implant insertion 
and the reentry was -0.17 ± 1.79 mm (minimum -4mm and maximum 2.5mm) 
demonstrating a slight overall bone resorption (Table 2) 
In the GBR group, 2 out of 10 (20%) implants demonstrated a vertical bone loss 6 
months after implant insertion. All other implants (80%) showed bone regeneration 
with a reduced defect height at the reentry surgery. The mean overall vertical bone 
gain was 1.79 ± 2.24 mm with a minimum of -2.5 mm and a maximum of 5 mm 
(Table 2). This difference in vertical bone height between implant insertion and the 
reentry procedure 6 months later was statistically significantly different between SH 
and GBR group (p=0.017, Mann Whitney test) favoring the GBR group. Regarding 
change in infrabony defect height (B), defect depth (D) and defect width (C), no 
statistically significant differences between the two groups were observed. 
 
Prosthetic reconstruction 
A total of 24 single crown reconstructions and 2 bridges were delivered to the 
patients. 57.1% of all the reconstructions were screw-retained and 42.9% cemented. 
All reconstructions were porcelain fused to metal reconstruction (PFM) except one 
single crown, which was a gold crown.  
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Follow-up examinations 
Implant and crown survival 
The implant and crown survival rate after 18 months was 100%, revealing no serious 
biologic or prosthetic complication. In the SH group, 2 ceramic chippings occurred in 
two patients 6 and 12 months after loading. Both could be polished with no further 
treatment.  
In the GBR group one cemented crown became loose 1 month after cementation 
and could be recemented again. In another patient with a screw-retained single 
crown, a screw loosening took place 18 months after prosthetic insertion.  
 
Probing pocket depth (PPD), sulcus bleeding index (SBI), plaque index (PI) 
All periimplant measurements including PPD, SBI and PI performed at the time of 
delivering the prosthetic reconstruction and at 3, 6, 12 and 18 months demonstrated 
healthy periimplant tissues with generally no statistical significant differences 
between the SH and the GBR group (Fig 2-4). The only periimplant parameter 
revealing a statistical significant difference (p=0.030) between the test und control 
sites was the probing pocket depths mesio-orally. 
 
Mucosa level 
After 18 months, the mean marginal mucosa level in the spontaneous healing group 
was located 3.33 ± 1.09 mm above the rough/smooth border of the implant. In the 
GBR group the mucosa was located 3.07 ± 1.43 mm above the rough/smooth border 
of the implant revealing no statistical significant differences between the two groups 
(Fig. 5). In addition, the mucosal level revealed a slight overall gain from reentry to 
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the 18 months follow-up without any statistical significant difference between the 
spontaneous group and the GBR group. 
 
Radiographic measurements 
The radiographic evaluation demonstrated that all implants were radiographically 
integrated indicated by a direct contact between the bone and the implant. The mean 
change in vertical bone level since crown insertion at the mesial and the distal site of 
the implants revealed a slight bone loss of -0.39 ± 0.49 mm for the SH group and a 
stable bone level of 0.02 ± 0.48 mm for GBR group after 18 months.  
 
Discussion 
The present randomized controlled clinical study demonstrated high implant and 
crown survival rates 18 months after crown insertion. All periimplant soft tissue 
parameters revealed healthy tissues, with no difference between sites, which were 
left for spontaneous healing versus sites that were treated with GBR procedures. 
With respect to the bone level, the spontaneous healing group demonstrated 
statistically significant more vertical bone loss at the buccal aspect 6 months after 
implant insertion and slightly more marginal bone loss between crown insertion and 
the 18 months follow-up appointment.    
In the present RCT a high survival rate of the implants of 100% could be found 
after a follow-up period of 18 months. This result was independent of whether or not 
a buccally exposed implant surface was left for spontaneous healing or was treated 
by means of GBR procedures. The implant survival rate in the present study is in 
agreement or slightly higher compared to a previously published systematic review 
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revealing an implant survival rate of 97.2% after 5 years (Jung et al. 2012). However, 
it has to be emphasized that the present observation period is rather short and further 
assessments of the study population are required.  
The mean vertical bone gain of the present study for the GBR group of 1.79 ± 2.24 
mm can be considered low compared to other studies indicating bone gains of 5.63 
mm using the same grafting materials as in the present study (Jung et al. 2009). This 
might be explained by the fact that the mean defect height at implant insertion was 
only 3.64 ±1.37 mm. Since the implant had a machined neck of 1.4 mm height which 
was included in the defect measurements, the mean defect height was only about 2.2 
mm from the smooth/rough border. The present study revealed that in the GBR 
group, in 2 out of 10 sites a vertical bone loss took place between implant insertion 
and reentry. These two sites revealed the smallest defects (1.5 to 2 mm).  
The question that is raised by the present study is whether or not in small bony 
dehiscence defects around implants a GBR procedure is necessary or not. This 
question has a high impact in clinical practice. Based on the limited number of 
patients it seems that the implant survival and the soft tissue stability was not 
influenced if a GBR procedure was performed or not on defects no bigger than 5 mm 
of exposed structured implant surface. In a previous retrospective clinical trial on 
immediate implants the dimension of the buccal bone and the mucosa was assessed 
using cone beam computed tomography after an observation period of 7 years (Benic 
et al. 2012). It was demonstrated that 30% of the implants revealed no 
radiographically detectable buccal bone at the 7-year control. Nevertheless, these 
implants revealed healthy soft tissue conditions with a mucosa level located only 1 
mm more apically than at implants with intact buccal bone. Based on the present 
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study and this clinical trial it might be speculated that stable soft tissue do not 
necessarily need a completely covered implant surface. 
Within the limitation of the present study, where only a small group of 22 patients 
were treated, the results have to be interpreted with caution and the study might be 
considered a pilot study. Further limitations are related to the fact that only premolars 
and molars were included and that no individual bite blocks for the Rx holder have 
been used. In addition, it was difficult to judge the exact amount of mineralized tissue 
at the time of the reentry surgery due to the fact that there was no histological 
assessment. For the careful evaluation of the bone and soft tissue more long-term 
studies with larger population have to be designed. The positive effect of the 
periimplant soft tissue stability over the 18 months period could be reduced after a 
longer loading time. 
 
 
 
Conclusion 
It can be concluded that small bony dehiscence defects that were left for 
spontaneous healing demonstrated high implant survival rates with healthy and 
stable soft tissues. However, they revealed more vertical bone loss at the buccal 
aspect within the first 6 months after implant insertion. Within the limits of the present 
study it seems that GBR procedures improve the stability of the buccal bone of 
implants with buccal bony dehiscence defects.  
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Figures and Tables: Legend 
 
Figure 1a,b: Defect dimensions measured at the time of implant placement and 
after reentry.  A: Vertical defect height from implant shoulder to first BIC; B: 
Infrabony defect height C: Defect width from width from mesial to distal bone crests; 
D: Defect depth from bone crest to implant surface 
 
Figure 2: Probing depth: Mean over all measurement sites (mean per implant) 
 
Figure 3: Sulcus bleeding index: Mean over all measurement sites (mean per 
implant) 
 
Figure 4: Plaque index: Mean over all measurement sites (mean per implant) 
 
Figure 5: Mucosa level: Mean over all measurement sites (mean per implant) 
 
Figure 6: Treatment example from the guided bone regeneration group 
6a) initial bone defect at implant placement in position 26 
6b) bone augmentation with DBBM 
6c) clinical findings at re-entry 6 months after implant placement 
6d) clinical findings at 18 months follow-up 
6e) Radiograph at 18 months follow-up 
 
 
 
Figure 7: Treatment example from the spontaneous healing group 
7 a initial bone defect at implant placement in position 36 
7 b clinical findings at re-entry 6 months after implant placement 
7 c clinical findings at 18 months follow-up 
7 e Radiograph at 18 months follow-up 
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Table 1: Distribution oft he implant positions (FDI classification) 
 
Table 2:  Bone changes from implant insertion to the reentry after 6 months (A_Diff, 
B_Diff, C_Diff, D_Diff; negative value = bone loss; positive value = bone gain), one 
implant selected per patient 
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 Fig 1a 
 
 
 
Fig 1b 
 
Figure 1a,b: Defect dimensions measured at the time of implant placement and after 
reentry.  A: Vertical defect height from implant shoulder to first BIC; B: Infrabony 
defect height C: Defect width from width from mesial to distal bone crests; D: Defect 
depth from bone crest to implant surface 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Fig 2 Probing depth: Mean over all measurement sites (mean per implant) including 
standard deviations 
 
 
Fig 3 Sulcus bleeding index: Mean over all measurement sites (mean per implant) 
including standard deviations 
  
 
 
 
Fig 4 Plaque index: Mean over all measurement sites (mean per implant) including 
standard deviations 
 
 
 
Fig 5 Mucosa level: Mean over all measurement sites (mean per implant) including 
standard deviations 
 
  
Fig. 6 Treatment example from the guided bone regeneration group 
6 a initial bone defect at implant placement in position 26 
6 b bone augmentation with DBBM 
6 c clinical findings at re-entry 6 months after implant placement 
6 d clinical findings at 18 months follow-up 
6 e Radiograph at 18 months follow-up 
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. 7 Treatment example from the spontaneous healing group 
7 a initial bone defect at implant placement in position 36 
7 b clinical findings at re-entry 6 months after implant placement 
7 c clinical findings at 18 months follow-up 
7 e Radiograph at 18 months follow-up 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables
 
Table 1: Distribution of the implant positions (FDI classification) 
 
 
  Treatment randomisation N Minimum Maximum Mean (mm) Std. Deviation Median 
A_Diff 
Spontaneous healing 12 -4 2.5 -0.17 1.79 0.00 
Guided bone regeneration 10 -2.5 5 1.79 2.24 1.75 
B_Diff 
Spontaneous healing 12 -0.5 2.5 0.29 0.78 0.00 
Guided bone regeneration 10 0 2.5 0.60 0.84 0.25 
C_Diff 
Spontaneous healing 12 -2.5 5 0.38 1.84 0.00 
Guided bone regeneration 10 -1 5 1.25 1.84 0.75 
D_Diff 
Spontaneous healing 12 -0.5 2 0.21 0.69 0.00 
Guided bone regeneration 10 0 2 0.40 0.66 0.00 
 
 
 
Table 2:  Bone changes from implant insertion to the reentry after 6 months (A_Diff, 
B_Diff, C_Diff, D_Diff; negative value = bone loss; positive value = bone gain), one 
implant selected per patient 
 
